Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-019848
Filing Date
2024-02-13
Accepted
2024-02-13 16:01:27
Documents
1
Group Members
NOVARTIS AGNOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245934d1_sc13ga.htm SC 13G/A 77884
  Complete submission text file 0001104659-24-019848.txt   79524
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Filed by) CIK: 0001297709 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94014 | Film No.: 24625530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)